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Investigating the role of Quaking in antigen uptake and cross-presentation by
dendritic cells
Yating Li, B.Sc.

Advisory Professor: Cassian Yee, M.D.

Dendritic cells (DCs) are considered the most potent antigen presenting cells
(APC) due to their superior capability of cross-presenting exogenous antigens to CD8+
T cell for strong adaptive immune responses. They internalize foreign antigens by
phagocytosis, endocytosis or macropinocytosis, which are then processed in
endosomal compartments and loaded onto MHC Class I molecules. However, the
molecular mechanisms regulating exogenous antigen uptake and cross-presentation
by DCs are not fully understood.
In this study, we discovered that an RNA-binding protein, Quaking (QKI) plays
a pivotal role in antigen uptake by DCs. Our previous studies in neural stem cells and
microglia have identified QKI as a novel regulator of phagosomes and endolysosomes,
and knocking down of QKI significantly downregulates genes involved in phagosome
maturation and endosome signaling. Furthermore, we have also shown that QKI
interacts with a nuclear receptor, PPARδ, in multiple cell types. The QKI- PPARδ
complex induces expression of a large set of genes associated with signaling in
phagosome and endolysosome by binding to their promoter regions. Therefore, we
hypothesize that in DCs, QKI and PPARδ mediated promotion of phagosome and
endolysosome signaling can enhance antigen uptake and cross-presentation function
of these cells.
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Using human monocyte derived DCs, we found QKI and PPARδ to be
significantly upregulated upon monocyte differentiation into DC in vitro. Our data have
demonstrated that activation of QKI/PPARδ complex by PPARδ receptor agonist
increases the phagocytosis activity in DCs while siRNA silencing of QKI or PPARδ
impairs it. This suggests that QKI cooperates with PPARδ to enhance the antigen
uptake by DCs. Our studies did not establish the role of either QKI or PPARδ in the
regulation of exogenous antigen cross-presentation by DCs following uptake.
Further investigation aimed at dissecting the mechanisms by which QKI/PPARδ
complex enhances antigen uptake will contribute to our current understanding of DC
biology and may provide new strategies to improve DC-based immunotherapy.
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Chapter 1: Introduction
1.1 Quaking
Quaking (QKI) is an RNA-binding protein, belonging to the signal transduction
and activation of RNA (STAR) protein family. It is encoded by the gene qk and has
three main isoforms (QKI5, QKI6, and QKI-7), generated by alternative splicing (Kondo
et al., 1999). As an RNA-binding protein, QKI is shown to affect translation, stability,
export, splicing of mRNA and microRNA biogenesis (Darbelli & Richard, 2016). The
physiological role of QKI has been mainly studied in the neural system. Ablation of
expression of QKI in mice impairs the formation of neural tubes and is embryonic lethal
(Noveroske et al., 2002). While the crucial role of QKI in oligodendrocytes to maintain
myelination has been established for decades (Hardy, 1998), the detailed mechanism
was only revealed recently (Zhou et al., 2020). Dysregulation of QKI causes various
neurological diseases. In ataxia and schizophrenia patients, the expression level of
QKI is significantly decreased in CNS (Åberg et al., 2006). Furthermore, chromosome
6q25-6q26 deletion, where qk is located, is found in 30% of glioblastoma cases (Yin et
al., 2009) indicating the tumor suppressing potential of QKI.
Using Pten-/-; Trp53-/- mouse model, which develops premalignant neural stem
cells (NSCs), Shingu et al have demonstrated the functional significance of QKI
deletion in gliomagenesis. Studies in this model showed that NSC specific deletion of
qk causes downregulation crucial genes involved in phagosome formation, clathrinmediated endocytosis, and endolysosome formation. This causes impairment of
receptor recycling and endolysosome-mediated protein degradation and subsequently
results in the sustained expression of proteins involved in self-renewal. This enables
1

glioma stem cells to maintain stemness even outside the niches and permits their
hyperproliferation during invasion and migration (Shingu et al., 2017).

Another study investigating the effect of QKI on mature myelin proposed a novel
mechanism where QKI function is independent of its RNA binding capacity (Zhou et
al., 2020). Instead, QKI-5 interacts with the PPARδ-RXRα nuclear receptor complex
as a co-activator, enhancing the expression of genes involved in lipid metabolism,
particularly fatty acid elongation and desaturation. When QKI is depleted in mouse
oligodendrocytes, which is essential for myelin production, the lipid component in
myelin is drastically decreased and results in demyelination-associated disease
phenotypes.

Recently, attention have been brought to the role of QKI in immune cells,
particularly monocytes and macrophages. De Bruin et.al showed that QKI is highly
expressed in atherosclerotic macrophages and reduction in QKI protein levels impaired
differentiation of monocytes to macrophage along with a decrease in the uptake of
lipoproteins by macrophages. The findings were also corroborated in study comparing
a unique QKI-haploinsufficient atherosclerosis patient with a healthy sibling with intact
copies of QKI (De Bruin et al., 2016).

Another study uncovered the anti-inflammatory role of QKI-5 in macrophages.
It was shown that silencing of QKI-5 in macrophage induces the M1-like polarization,
that is characterized by an increase in TNF-α and IL-6 production and a decrease in
IL-10 secretion (L. Wang et al., 2017). Mechanistically, it was found that QKI-5 binds
and represses NF-κB thereby limiting the STAT1-NF-κB pathway. In mouse model,

2

macrophage-specific depletion of QKI renders them sensitive to endotoxin challenge
while overexpression of QKI-5 protected the animals against LPS-induced endotoxin
shock.

Although novel functions of QKI in monocytes and macrophages have been
discovered, our understanding of QKI under both physiological and disease conditions
is still incomplete. Further, besides macrophages, DCs also arise after the
differentiation of monocytes in response to different stimulus. These monocyte-derived
dendritic cells play an important role in bridging the innate and adaptive immunity under
inflammation conditions and are of great therapeutic importance. The contribution of
QKI to the DC biology and to the large myeloid cell population still awaits elucidation.

3

1.2 PPARδ
Peroxisome proliferator-activated receptor (PPAR) δ, belongs to PPAR nuclear
receptor family that consists of PPARα, PPARγ, and PPARβ/δ. Members of this
receptor family largely differ in their tissue distributions, ligand specificities, and
functions. While PPARα is preferentially expressed in liver, kidney and muscles, and
PPARγ is mainly found in adipose tissue and macrophage, PPARδ is relatively
ubiquitously expressed cross various cell types and is the least understood one among
the three (Biologie & Cellulaire, 1996).

The crystal structure of PPARδ has been resolved (Zoete et al., 2007) and
similar to the other two PPARs, it consists of a ligand binding domain (LBD), a DNA
binding domain, a hinge and two activation function (AF) motifs. The LBD binds to a
wide variety of ligands, which includes but is not limited to polyunsaturated lipid,
lipoproteins, and their derivatives. Additionally, synthetic ligands such as GW501516,
have been developed with high specificity and effectivity with therapeutic potential for
metabolic diseases. Moreover, the LBD also induces the formation of a heterodimer
with another nuclear receptor, RXR family receptor. This PPAR/RXR interaction is
common to all three PPARs and is essential for their functions, which is to modulate
their targeting genes by binding to PPAR response elements located in the promoter
regions (Nolte et al., 1998). However, there is also evidence suggesting that PPARδ
could specifically interact with β-catenin (Scholtysek et al., 2013), or NF-κB instead of
RXR to regulate a different set of genes (Adhikary et al., 2015). In addition to their
heterodimer partners, PPARs also interact with co-factors, either co-activators or cosuppressors, adding another layer of the complexity. The recruitment of co-factors
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depends on the type of ligand, agonist or antagonist, that induces different
conformational changes in the LBD and the AF-2 motif, resulting in distinct functions.
QKI-5 has been found to be one of the co-activators that form a protein complex with
PPARδ and RXRα to regulate a large set of gene expression in neural stem cells,
oligodendrocytes and microglia, as mentioned previously (Zhou et al., 2020).

PPARδ is the least characterized protein among PPARs. Functional
significance of PPARδ has been mostly focused on fatty acid metabolism and glucose
homeostasis and knocking out ppard in mice predisposes the development of high fat
induced obesity (Y. X. Wang et al., 2003). Moreover, treatment with a PPARδ agonist
enhances insulin secretion and promotes fatty acid oxidation, thereby decreasing body
fat in mouse. There is also evidence suggesting that PPARδ enhances mitochondrial
function by promoting expression of genes involved in mitochondria respiration
(Ravnskjaer et al., 2010).

The physiological role of PPARδ inflammation has been studied, though with
contradicting findings. Some studies such as those conducted in EAE mouse model
revealed its anti-inflammatory role in autoimmune diseases. The PPARδ agonist
treatment could reduce production of pro-inflammatory cytokines TNFα and MCP-1
and reduce the disease severity (Dunn et al., 2010). On the contrary, other studies
have indicated the pro-inflammatory functions of PPARδ. In psoriatic skin condition,
PPARδ is found to be significantly elevated and induces TNFα secretion (Romanowska
et al., 2010). Moreover, in monocyte-derived macrophages, PPARδ can bind to NF-κB
and STAT1 and consequently represses their activation of downstream proinflammatory genes (Adhikary et al., 2015). It is also been shown that deletion of
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PPARδ in macrophages decreases their phagocytic capacity, thereby limiting their T
cell activation function (Mukundan et al., 2009). The role of PPARδ in inflammation,
especially in immune cells, still remains inconclusive.

6

1.3 Dendritic Cells
Dendritic cells (DCs) are first described by Steinman and Cohn (Steinman &
Cohn, 1973). They are named after the dendrite-like membrane protrusions. Their
crucial roles in bridging the innate immunity to adaptive immunity was established in
later studies.
DCs constantly survey the environment, detect pathogens, and relay the threat
to T cells. They express a wide range of pattern recognition receptors (PRRs). PRRs
can be activated by pathogen-associated molecular patterns (PAMPs) and dangerassociated molecular patterns (DAMPs) that are often found in bacteria, parasites, or
virus-infected cells. Once DCs get activated by pathogens via PRRs, they present the
antigens to the T cell through Major Histocompatibility Complex (MHC) molecules.
Extracellular antigens are internalized, processed into antigenic peptides and loaded
onto MHC class II molecules for CD4+ T cell activation. In contrast, the intracellular
antigens are processed and loaded onto MHC class I molecules to specifically bind
TCRs on CD8+ T cell. In the cases when DCs are not infected by pathogens, they are
still able to present extracellular antigens to CD8+ T cells through cross-presentation,
a process that is unique to professional antigen presenting cells (APCs). DCs are not
the only APCs capable of cross-presentation. Macrophages, B cells, and even a subset
of endothelial cells under certain circumstances can cross-present and activate CD8+
T cells. Yet, DCs facilitate the T cell activation by not only being able to effectively
present peptide-bound MHC, but also express co-stimulatory molecules and cytokines
for strong T cell activation (Wculek et al., 2020).
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DCs at a resting state constantly sample and internalize the surrounding
environment for evaluation of any potential threat even though no PRRs are activated.
DCs at this state are considered immature (iDCs). Upon PRR stimulation, iDCs quickly
upregulate MHC class I and class II expressions, load antigenic peptides on MHC
molecules and prepare for antigen presentation to T cells. At the same time, costimulatory molecules such as 4-1BBL and OX40L are also increased to provide
second stimulatory signal for T cells. In addition, depending upon the type of stimulus,
DCs also secret cytokines, such as IL-4, to modulate naïve T cell differentiation. DCs
at this stage are called mature DCs (mDCs).
DCs represent heterogenous populations with different ontogeny and
physiological roles. They are classified into conventional DCs (cDCs), plasmacytoid
DCs (pDCs), and inflammatory DCs. cDCs and pDCs are derived from precursor cells
in the bone marrow whereas inflammatory DCs are differentiated from circulating
monocytes under inflammation.
Among different types of DC, cDCs are the major population present at steady
state. It consists of cDC1 and cDC2 and they are associated with presenting antigens
to CD8+ and CD4+ T cells, respectively. Their critical role in the induction of protective
immunity against bacterial and viral infection as well as different types of tumors has
been extensively studied (Wculek et al., 2020). In contrast, pDCs are known for their
inability to cross-present antigens at steady state. pDCs are specialized in type I
interferon production in response to viral infection. Inflammatory DCs can be found at
the site of injury or infection in vivo. They express high levels of co-stimulatory
molecules such as CD80, CD86, as well as MHC molecules. In addition, human CD14+
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monocytes could be differentiated to DCs ex vivo. These monocyte derived DCs
(moDCs) exhibit similar transcription profile as in vivo inflammatory DCs, making them
a good model to study DC biology. In fact, moDCs are widely used in cancer
immunotherapy as DC vaccines alone or for the ex vivo generation of antigen-specific
T cells with their anti-tumor effect proven by several clinical trials (Wculek et al., 2020).
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1.4 Antigen uptake by dendritic cells
Dendritic cells are considered the most effective antigen presenting cells due to
their superior ability to stimulate antigen-specific T cell responses. As APC, one of their
key functions is to constantly sample the external environment and internalize the
particles outside the cells, ranging from pathogens to apoptotic cells. The route of
antigen uptake by DCs can be broadly categorized into clathrin-mediated endocytosis,
phagocytosis, and micropinocytosis.
1.4.1 Clathrin-mediated endocytosis
Clathrin-mediated endocytosis is the most extensively studied mode of
endocytosis, although detailed molecular mechanism studies have not been conducted
with DCs. This mechanism has been shown to be highly conserved across species
and different cell types (McMahon & Boucrot, 2011). The process is initiated when a
membrane invagination is formed, preferentially at the PtdIns(4,5)P 2-rich membrane
region. Upon endocytic receptor activation, a key adaptor protein, AP2 is recruited to
the membrane curvature and binds to both PIP2 and receptor bound cargo (Höning et
al., 2005). Clathrin is subsequently recruited to the cargo by AP2 and other adaptor
proteins followed by quick polymerization into a clathrin-coat that wraps the outer edge
of the invagination, thereby stabilizing it. As the coated pit extends to its maximal size,
it internalizes sufficient particles and deforms from the plasma membrane. At this stage
another protein dynamin is recruited to the neck of the vesicle and induces vesicle
budding (Kosaka & Ikeda, 1983). When a clathrin-coated vesicle is cleaved off from
the plasma membrane and fully internalized, HSC70 and Auxilin will dissemble the
clathrin coat, releasing clathrin back to the cytosol and ready for next round of
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endocytosis (Massol et al., 2006). Together, a freshly formed endosome is released
for further trafficking and processing.
Clathrin-mediated endocytosis is responsible for internalizing a great variety of
small molecule such as antibodies, lipoproteins and immune-complexes for
presentation. The functional significance of endocytosis is not limited to antigen
uptake. Chemokine and cytokine receptors such as CCR5 and IL4 that are highly
expressed in DCs, are able to induce clathrin-mediated endocytosis to activate
perspective signaling pathways and to recycle the receptors (McMahon & Boucrot,
2011).
1.4.2 Phagocytosis
In contrast to clathrin-dependent endocytosis, phagocytosis is dependent on
remodeling of actin cytoskeleton (Freeman & Grinstein, 2014). It is worth noting that
DC, as well as other professional phagocytes, such as macrophages, constantly
exhibit filopodia and membrane ruffles, allowing their maximal encounter with the
environment (Patel & Harrison, 2008). These membrane protrusions are formed by the
cortical F-actin. Phagocytosis is initiated upon the engagement of a phagocytic
receptor with targeted particles, leading to the disruption of the steady state actin
cytoskeleton at the cortical membrane. When F-actin is debranched and nucleated,
the lateral mobility of other phagocytosis receptors significantly increases, leading to
an amplified signal for phagocytosis (Jaumouillé et al., 2014). Next, the F-actin
monomers polymerize and form pseudopodia to internalize the particle. This step
involves Cdc42, Rho- and Rap-family GTPases that regulate a large number of actin
nucleation and polymerization proteins such as Arp2/3, coronins, and cofilins, as well
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as some lipid mediators for protein anchoring (Rohatgi et al., 1999) (Yan et al., 2005)
(Cai et al., 2007). However, largely due to the complexity of various upstream signals
from different phagocytosis receptors the detailed molecular mechanisms regulating
this step are still not completely elucidated. Finally, when the pseudopodia are
extended to the maximal size and sealed the phagocytosis cup is terminated. At this
point actin filaments are depolymerized and removed from the nascent phagosome
(Marion et al., 2012).
Although formation of a phagosome requires consistent remodeling of the
cortical cytoskeleton, the initiation driving force and the phagocytosis receptors can
vary widely. Receptors that induce phagocytosis can be broadly classified into Fc
receptors, scavenger receptors and integrins, which are all highly expressed in DCs
(Freeman & Grinstein, 2014). Fc receptors bind to Fc portion of different classes of
immunoglobulin, thereby recognizing opsonized particles. With their structural
diversity, scavenger receptors can recognize a wide range of targets. For example,
CD36 binds to oxidized lipids, commonly found on apoptotic cells (Jaqaman et al.,
2011). Integrins, on the other hands, can be stimulated by not only specific targets
(both opsonized and non-opsonized), but also by the increase in cellular rigidity (Abram
& Lowell, 2009). Bacterial cells are thousand times more rigid than normal human cells
or apoptotic corpses (Tuson et al., 2012). This mechano-signal can be sensed by
integrins to distinguish between self and non-self-cells.
Multiple types of phagocytosis receptors can be co-expressed on a single DC.
While each receptor has distinct selectivity, yet they can overlap extensively. These
receptors collaborate to recognize a wide range of particles. One of the advantages of
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this receptor interaction is that enables targeting of several regions recognized by
different receptors on any particular particle (Uribe-Quero & Rosales, 2017).
Simultaneous engagement of several receptors enables DCs to detect particles
present at low concentrations in the environment and enhances the sensitivity of these
particles for phagocytosis.
1.4.3 Macropinocytosis
Apart from clathrin-mediated endocytosis and phagocytosis, DCs also exhibit
constant engulfment of extracellular milieu in a non-specific manner. This process is
known as macropinocytosis (Liu & Roche, 2015) (Canton, 2018). Early studies have
suggested that DCs as well as macrophages actively perform macropinocytosis in a
relatively large volume and an entire cell can be internalized within an hour. The
extensive energy spent on macropinocytosis alludes to its functional significance.
However, compared to other forms of cellular engulfment, macropinocytosis still
remains a less studied and underappreciated form.
Unlike endocytosis and phagocytosis which require receptors to recognize
specific molecules on foreign particles or abnormal cells, macropinocytosis is initiated
from the membrane ruffles that are induced by a calcium sensing GPCR, CaSR, in
response to extracellular calcium, which is often elevated at the site of injury or
infection (Canton et al., 2016). Due to its non-selectivity, a foreign antigen can only be
internalized only when it is present in high concentrations. However, similar to
phagocytosis, macropinocytosis also requires actin remodeling and is regulated by
similar aforementioned actin remodeling machinery (Redka et al., 2018).
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One of the reasons that macropinocytosis is less understood is that it is
challenging to target it specifically. For example, inhibitors that prevent actin
polymerization will simultaneously affect phagocytosis and micropinocytosis making it
challenging to distinguish the two phenomena. Using different sized fluid tracer or
dextran also fails to differentiate macropinocytosis from endocytosis due to the overlap
of particle sizes that they are able to recognize. Some studies employed tagged-OVA
to evaluate macropinocytosis in DCs. However, later it was shown that tagged-OVA
can indeed be recognized by mannose receptor to induce phagocytosis (Autenrieth &
Autenrieth, 2009). Therefore, further studies to differentiate these modes of cellular
engulfment requires development of highly specific and efficient inhibitors or
genetically knockout models.
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1.5 Antigen processing and presentation
After being internalized, antigens need to be processed to peptides before being
loaded to the MHC molecules. The size of antigenic peptides is restricted by the
binding groove of MHC molecules. For MHC class I, this length is restricted to 8 to 11
amino acids while the number of amino acids in the peptide chain ranges from 14 to
18 for MHC class II molecules.
In classical MHC class I presentation, where endogenous antigens are
presented to CD8+ T cells, antigenic peptides are generated by cytosolic proteasome
and subsequently recruited to the endoplasmic reticulum (ER) lumen by transporter
associated with antigen processing (TAP) (Halenius et al., 2015). In the ER lumen,
TAP forms a peptide-loading complex (PLC) with ERp57, tapasin, calnexin,
calreticulin, and ER aminopeptidase (ERAP) (Wearsch & Cresswell, 2007). PLC is
responsible for the final trimming and loading of peptides on MHC class I molecules
within the ER lumen (Peaper et al., 2005). Following the loading of the peptide, the
peptide-MHC complex (pMHC) is transported to the cell membrane for T cell activation.
Loading of exogenous peptides to the MHC class II molecules occurs in a
specialized endosomal compartment called MHC class II compartment (MIIC) (Roche
& Furuta, 2015). Pathogens are internalized and temporarily stored in either endosome
or phagosome (depending on the mode of antigen uptake), which fuses with early
endosome and then MIIC (Neefjes, 1999). The MIIC is highly acidic and contains
various lysosomal proteases that can degrade exogenous pathogens. In addition, the
newly synthesized or recycled MHC class II molecules are also delivered from ER or
early endosomes to the MIIC, respectively (Griffin et al., 1997). Before reaching the
15

MIIC, MHC class II molecules are associated with the invariant chain (Ii) protein that
prevents suboptimal loading of random peptides during trafficking. Once inside the
MIIC, Ii is replaced by Class II-associated Invariant chain Peptide (CLIP). CLIP is not
removed until the peptide with highest affinity to MHC class II molecules is selected.
Lastly, the pMHC complex is delivered to the plasma membrane. This trafficking along
the endocytic pathway is guided by Rab family GTPases. Rab5 marks the newly
formed endosomes and early endosomes, which is exchanged for Rab7 that marks
the late endosomes (Bertram et al., 2002). Depletion of either one impairs the fusion
of endosome with MIIC, thereby reducing MHC class II presentation (Egami et al.,
2014).
The mechanism for presentation of endogenous antigens has been extensively
studied and characterized. Yet there is limited understanding of cross-presentation of
exogenous antigens to MHC class I molecules. To explain this phenomenon, two major
pathways have been proposed and widely accepted, namely cytosolic and vacuolar
pathways. However, to what extent these two pathways contribute to the overall crosspresentation is still debatable and difficult to quantify. Currently most evidence points
to the cytosolic pathway (Schuette & Burgdorf, 2014).
In the vacuolar pathway, the internalized antigens remain in the endosomal
compartments all the time (Joffre et al., 2012). Starting from early endosome or
phagosome, the fusion with late endosome to exposure of antigens to proteases in the
lysosome that degrade antigens to antigenic peptides and subsequent loading of the
peptides to the MHC class I molecules. However, the highly acidic environment in the
endolysosome is not optimal for antigen loading (Delamarre et al., 2005). Antigenic
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peptides may be trimmed into individual amino acids before being loaded to MHC class
I molecules, thereby limiting the cross-presentation. DCs, as potent APCs, have
evolved mechanisms to overcome these limitations. NADPH oxidase 2 (NOX2)
consumes proton for ROS production and can thus slow down the acidification
process. NOX2 is specially recruited to the endosomal compartments in the DCs with
help from Rab27a and Rac1 (Savina et al., 2006). In addition, V-ATPase is expressed
to a lower level in DCs compared to other phagocytes, which further reduces the level
of protons present in the endosomal compartment and enhances the availability of
peptides for cross-presentation (Savina et al., 2006). Cross-presentation utilizing this
pathway is sensitive to lysosomal protease inhibitors, such as cathepsin S inhibitor,
whereas the cytosolic pathway is sensitive to proteasome inhibitors, suggesting the
involvement of cytosolic proteases in the processing of antigens for cross-presentation.
The cytosolic pathway requires antigens to be transported from early endosome
or phagosome to the cytosol. How antigens, which may be large in size, get actively
transported across endosomal membranes still remains unanswered. Although
accumulating evidence suggests the involvement of ER associated degradation
(ERAD) machinery in this process (Ackerman et al., 2006), some studies also support
the idea that endocytic membrane disruption leads to antigen leakage (Dingjan et al.,
2016). The antigen degradation following transportation to the cytosol is found to hijack
the mechanism that is utilized by the classical MHC class I presentation. Specifically,
TAP and ERAP are shown to be responsible for antigen degradation for crosspresentation. They are found in the endosomes containing peptide-loaded MHC for
final transport to the plasma membrane. However, this does not exclude the possibility
that these proteins are recruited to the antigen-containing endosomes before antigen
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digestion, in which case it is not necessary for antigens to be exported outside
endosomes for degradation.
Nevertheless, the crucial role of the Rab family GTPases is not questionable.
They are involved in sorting, trafficking, and processing of various endosomal
compartment. A study screening 52 Rab proteins in a murine DC-like cell line revealed
that 12 of them are essential for antigen cross-presentation (Zou et al., 2009). The
functional significances of some of them have been reported. For example, Rab27a
contributes to the incorporation of NOX2 to the endosomes (Jancic et al., 2007). Rab11
recruits the MHC class I molecules to the antigen-containing phagosomes (Ullrich et
al., 1996). Rab34 guides the fusion of phagolysosomes (Egami et al., 2014).
Our current understanding of antigen cross-presentation in DCs remains
incomplete and the proposed models cannot be fully supported by existing evidence.
Moreover, many of these studies are conducted in murine system. Whether these
findings in mouse can be validated in human cells is still unclear and warrants further
research in this area.
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Figure 1: Intracellular pathways for cross-presentation in dendritic cells.
After being taken up, exogenous antigens are processed in two different pathways. In
the vacuolar pathway, the antigens are degraded and processed in the
endosomes/phagosomes by fusing with protease-containing lysosomes and MHC
Class I-containing recycling endosomes. The exogenous antigens can also be
exported to the cytosol and degraded by cytosolic proteasomes. Processed antigens
are transported into ER for MHC Class I loading. Alternatively, they can be transported
back to endosomes/phagosomes for MHC Class I loading and surface presenting.
TAP, transporter associated with antigen processing; NOX2, NADPH oxidase 2;
ERAP, ER-associated aminopeptidase; IRAP, insulin-responsive aminopeptidase.
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Chapter 2: Materials and Methods
2.1 Generation of human monocyte derived DCs
CD14+CD16- monocytes were isolated from previously frozen leukapheresis
products from healthy donors using EasySepTM human monocyte isolation kit
according to manufacturer’s instructions (STEMCELL Technologies). Cells were
cultured in 6-well plates at 0.67 × 106 cells/ml in 3 ml of AIM-V containing 800IU/ml of
GM-CSF and 500 IU/ml of IL-4 for 7 days as previously described (ref). Mature DCs
were stimulated with 100 ng/ml of LPS for 24 hours before being harvested.
2.2 Isolation of Peripheral Mononucleocytes (PMN)
PMNs were isolated from a buffy coat obtained from MD Anderson Blood Bank
using the gradient centrifugation method. Briefly, in a 50 ml canonical tube, 20 ml of
diluted blood was layered on top of 10 ml of Histopaque-1077 (Sigma-Aldrich) and 10
ml of Histopaque-1119 (Sigma-Aldrich). After centrifugation for 30 minutes at 2000
rpm, the layer between Histopaque-1077 and Histopaque-1119, which contained
PMNs, was collected. PMNs were washed with RPMI-1640 (Gibco) and counted
before subjecting them to three rounds of freeze/thaw for cell lysis.
2.3 Generation of M27 CTLs
The MART-1 specific cytotoxic T cell lymphocytes (M27 CTLs) was generated
as previously described (Park et al., 2017). Briefly, PBMCs isolated from leukapheresis
products were cultured in AIM-V media containing 800 IU/ml of GM-CSF and 500 IU/ml
of IL-4 for 7 days for generation of DCs. DCs were matured using 2 ng/ml of IL-1β,
1000 IU/ml of IL-6, 10 ng/ml of TNFα and 1 μg/ml of prostaglandin E2 for at least 18
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hours. Matured DCs were harvested and pulsed with 40 μg/ml of M27 peptide
(PolyPeptide Group) and 3 μg/ml of β2-microglobulin (Scripps Laboratories) in PBS
containing 1% of human serum albumin (Life Technology) for 4 hours at room
temperature before they were washed and irradiated. Peptide pulsed DCs were
subsequently used to co-culture with PBMCs at ratio of 1:10 in presence of IL21 and
low does IL-2. The DC stimulation took two rounds and each round took 7 days. M27tetramer+ CD8+ cells were sorted at the end of DC stimulation and expanded using the
rapid expansion protocol (Park et al., 2017).
2.4 Co-immunoprecipitation
Cells were cross-linked in 1% formaldehyde for 10 minutes at 37C and then
neutralized by Glycine before harvested. Cells were subsequently incubated in 0.3%
NP-40 lysis buffer supplemented with proteinase inhibitor at 4C for 30 minutes and
centrifuged for 30 minutes. Cell lysate was sonicated using a Dounce biohomogenizer.
Protein concentrations were quantified using Bradford Assay (BioRad) as
manufacturer instructed. Isolated proteins were incubated with indicated antibodies
overnight

at

4C

before

DynabeadsTM

protein

G

for

immunoprecipitation

(ThermoFisher) was added to the mixture to pull down the QKI-5/PPARδ complex. The
immunoprecipitation products were subjected for immunoblotting.
2.5 Immunoblotting
Cells were harvested, washed with ice-cold PBS and lysed in RIPA lysis buffer
(ThermoFisher). Protein concentrations were quantified using Bradford Assay
(BioRad) as manufacturer instructed. 15-30 μg of protein was subjected to SDS-PAGE
on a NuPAGETM polyacrylamide gel (ThermoFisher) and transferred to a nitrocellulose
21

membrane using the TurboTM Trans Blot system (Bio-Rad). The membrane was
blocked in 5% non-fat milk overnight 4C and incubated with indicated primary
antibodies for at least 4 hours. The membrane was then washed and incubated with
HRP-conjugated secondary antibodies before visualized using SuperSignal TM
chemiluminescence system (Thermo Fisher).
2.6 siRNA Knockdown
Several siRNAs targeting QKI-5 and PPARδ were obtained from Dharmacon.
N-TERTM Nanoparticle siRNA transfection system was used to transfect 50 nM siRNAs
to DCs according to manufacturer’s instructions. Transfecting media were removed 24
hours post transfection and fresh media were replenished.
2.7 Quantitative RT-PCR

Cells were harvested and washed three times in PBS before RNA isolation.
Total RNA was isolated using the RNeasy Mini Kit (Qiagen) following manufacturer’s
instructions. RNA concentration was determined by NanoDrop spectrophotometer
(ThermoFisher Scientific). The reverse transcription reaction was performed on the
same amount of RNA across different samples, using the M-MLV Reverse
transcriptase

(ThermoFisher

Scientific)

as

per

manufacturer’s

instructions.

Quantitative PCR was performed in duplicates using SYBRTM Select Master Mix
(Applied Biosystems) and QuantStudio 5 Real-Time PCR System (ThermoFischer
Scientific) according to manufacturers’ instructions. The housekeeping gene Rpl13a
was used for normalization. The primers used are listed as follow: Qk forward:
ATCCTATTGAACCTAGTGGTGTA,
Ppard

forward:

reverse:

GGTCAGAAGGTCATAGGTTAGTT;

CTCTATCGTCAACAAGGACG,

reverse:
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GTCTTCTTGATCCGCTGCAT;
reverse:

Cpt1a

forward:

CCACCAGTCGCTCACGTAAT;

CAGGCCGAAAACCCATGTTG,
Pdk4

forward:

ACAGACAGGAAACCCAAGCC, reverse: TTGCCCGCATTGCATTCTTA; Rpl13a
forward: CCTCAAGGTCGTGCGTCTGA, reverse; TCCACGTTCTTCTCGGCCTG.

2.8 Phagocytosis Assay
The Phagocytosis Assay Kit (IgG FITC) (Cayman Chemical) was used to
evaluate the phagocytic capacity. Cells were harvested and resuspended at a
concentration of 1 × 106 cells/ml. The latex beads-rabbit IgG-FITC complex was
directly added to the cell suspension at a final dilution of 1:200. Cells were
subsequently cultured at 37C for indicated periods of time. Before measuring the
fluorescent signal on a flow cytometer, cells were briefly resuspended in trypan blue
for 5 minutes to quench the surface signal, in order to distinguish the internalized beads
from surface bound beads.
2.9 Flow cytometry
All antibodies for flow cytometry were procured from Biolegend. The panel
consisted of CD36-FITC (336204), CD8-APC/Cy7 (344714), Ki67-PE (1512109), IFNγBV650 (502538), perforin -PE/Cy7 (353316), granzyme B-APC (372204), HLA-DRBV421 (307636), CD80-BV510 (305233), CD83-BV785 (305338), and CD86-BV650
(105035). For surface markers, cells were treated with TruStain FcX TM (Biolegend,
422301) as instructed by the manufacturer before staining with antibodies at a dilution
of 1:100 for 15 minutes at room temperature. Stained cells were subsequently washed
three times with ice-cold PBS supplemented with 1%FBS before acquiring data by
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flow-cytometry. For intracellular staining, cells were treated with Brefeldin A (Life
Technology) to block the secretion of cytokines for 18 hours. The Intracellular Fixation
and Permeabilization Buffer Set (Invitrogen) was used for intracellular antibody
staining according to manufacturer’s instructions. Antibodies against intracellular
targets were used at 1:50 dilution. All FACS data was acquired using Novocyte flow
cytometer and analyzed using FlowJo software (Tree Star).
2.10 Statistics
Data analysis was performed using GraphPad Prism 8 (GraphPad Software
Inc). Data were presented as mean  s.e.m. Statistical tests were considered
significant if P-values were  0.05
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Chapter 3: Results
3.1 Expression of QKI-5 and PPARδ in dendritic cells
First, to validate the expression of QKI-5 and PPARδ complex in human
monocyte derived dendritic cells (moDCs), immunoblotting against QKI-5 was
performed to detect protein levels of QKI-5 and PPARδ. Generation of moDC started
with peripheral monocytes, which were cultured in medium containing GM-CSF and
IL-4 for 6 days to induce their differentiation to immature DCs. Maturation of iDCs can
be stimulated by various PAMPs or DAMPs, commonly used are TNFα in combination
with IL-1β, or LPS alone. QKI-5 protein was not detectable in freshly isolated
monocytes. However, its expression was detectable as early as 2 days after
differentiation into iDCs and increased till day 4 and then remained stable till day 6,
suggesting QKI-5 plays a specific role in moDCs. Mature DCs (mDCs), either TNFα
induced or LPS induced, also expressed QKI-5 at a similar level to the Day 4 and Day
6 iDCs. The protein expression of PPARδ showed the same trend as QKI-5. However,
RXRα, a common heterodimerization partner of PPARδ was expressed at very low
levels in day 4 and day 6 iDCs and was not detectable in monocytes and mDCs (Fig
2).
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Figure 2:
1 |QKI5
QKI5and
and
PPARδ
were
upregulated
upon
monocyte
differentiation.
CD14+CD16- monocytes isolated from peripheral blood were cultured in AIM-V
medium containing 800 IU/ml of GM-CSF and 500 IU/ml of IL-4 for indicated periods
of time. Mature DCs were cultured for 6 days and then stimulated with either 10 ng/ml
of TNFα or 100 ng/ml of LPS for an additional 24 hours. Cells were lysed using RIPA
lysis buffer supplemented with protease inhibitor. Protein levels were measured by
immunoblotting. D2, day 2; D4, day 4; D6, day6; iDC, immature DC; mDC, mature DC.
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Next the association of QKI-5 is with PPARδ in the moDCs was determined.
PPAPδ was immunoprecipitated from iDCs. QKI-5 antibody and IgG were used as
positive and negative controls, respectively. QKI-5 was detected in the QKI-5- and
PPARδ- but not rabbit IgG-immunoprecipitated aggregates, indicating the association
of QKI-5 and PPARδ in moDCs (Fig 3). Together, these data suggested a potential
distinct function of QKI-5/PPARδ complex in moDCs that is absent in monocytes.

IP
4% Input QKI5

PPARβ
PPARδ

IgG

IB:IB:QKI-5
QKI5

SE

IB: QKI-5

LE

Figure 3:
2 | QKI5
QKI5 and
and PPARδ
PPARδ were
were associated
associated in
in iDCs.
iDCs.
Immature DCs were generated from CD14+CD16- monocytes using GM-CSF and IL-4
for 6 days as previously described. Cells were cross-linked and then neutralized before
protein isolation. QKI-5, PPARδ, and IgG were immunoprecipitated using protein G
beads. Rabbit IgG antibody was included as negative control. The immunoprecipitated
proteins

were

then

subjected

to

immunoblot

for

QKI-5

expression.

IP,

immunoprecipitation; IB, immunoblotting; SE, short exposure; LE, long exposure.
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3.2 Effect of PPARδ agonist on phagocytosis by dendritic cells
To investigate the role of QKI-5/PPARδ complex in antigen uptake and crosspresentation. PPARδ specific agonist, GW501516, was used to enhance the function
of the QKI-5/PPARδ complex. The optimal drug treatment scheme was determined
based on the surface expression of the scavenger receptor CD36, a common target of
QKI-5 and PPARδ. Adding GW501516 on the day when monocytes were plated
enhanced the surface expression of CD36 to the maximum. Treatment of the cells for
48 hours resulted in a very small increase in CD36 (Fig 4). In addition, GW501516 did
not enhance the CD36 surface level in mDCs. This was expected since DCs are known
to suppress the antigen uptake machinery when matured. It is also worth noting an
increase in the concentrations of GW501516 for treatment of the cells did not lead to
a further increase in the expression of CD36, suggesting it was saturated at 100nM.
GW501516 also increased the mRNA expression levels of other QKI-5 and PPARδ
common targets, namely Cpt1a and Pdk4, in iDCs generated from three healthy donors
(Fig 5), suggesting GW501516 is able to enhance the function of QKI-5/PPARδ
complex.
To test if enhancing the function of QKI-5/PPARδ complex affects the
differentiation of moDCs, CD14 and CD209 expressions were assessed by flow
cytometry. Monocytes express high levels of CD14, which is significantly reduced upon
differentiation to moDCs. CD209 is a moDC-specific marker and is drastically
upregulated in response to IL-4 during moDC differentiation (Sander et al., 2017).
When monocytes were cultured in presence of GM-CSF and IL-4, CD14 expression
were reduced to the same levels in different concentrations of GW501516-treated and
vehicle-treated cells. Similarly, CD209 increased to the same extent regardless of the
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treatments that cells received (Fig 6). Furthermore, the differentiation efficiency (i.e.
number of moDCs harvested/the number of monocytes plated) did not differ between
GW501516-treated or untreated cells. In sum, PPARδ agonist does not the affect the
the differentiation process of moDCs.
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4:| GW501516
Immature DCs were generated from CD14+CD16- monocytes using GM-CSF and IL-4
for 6 days as previously described. Mature DCs were stimulated with 100 ng/ml of LPS
for an additional 48 hours. iDCs or mDCs were treated with GW501516 at indicated
concentrations for 7 days (top) or 2 days (bottom). Cell surface expression of CD36
was measured by flow cytometry. MFI, mean fluorescent intensity.
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Figure 5: GW501516 upregulated QKI5 targets in iDCs
Immature DCs were generated as previously described. PPARδ agonist, GW501516
was added on day 0 of the cell culture at indicated concentrations. Expression levels
of QKI-5 targeting genes, Pdk4 and Cpt1a, were analyzed via quantitative real-time
PCR. Relative expression to untreated samples is plotted here. RPL13A was used a
housekeeping gene for normalization. Data represent results from 3 healthy donors. n
= 2. P values were calculated using two-way ANOVA and adjusted for multiple
comparison using the Benjamini, Krieger and Yekutieli FDR correction; ns, not
significant, *P ≤ 0.05; ****P ≤ 0.0001.
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Figure 6: GW501516 did not affect the differentiation of moDCs
Monocytes were isolated from human PBMCs. Immature DCs were generated as
previously described. PPARδ agonist, GW501516 was added on day 0 of the cell
culture at indicated concentrations. Cell surface expression of CD14 (Left) and CD209
(Right) were measured by flow cytometry. The histogram represents three independent
experiments.
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Next, the effect of GW501516 on the phagocytosis by moDCs was evaluated
using fluorescent labeled latex beads. When the beads were added to the DC culture,
the magnitude of the fluorescent signal emitted by DCs indicated the quantity of beads
that were internalized by the DCs, reflecting their phagocytic capacity. In DCs
generated from three healthy donors, GW501516 increased the phagocytic capacity of
iDCs to various degree at 48 hours (Fig 7). Again, mDCs were expected to exhibit low
phagocytic activity. Surprisingly, GW501516 was able to enhance phagocytosis by
mDCs in one donor but not the other two, suggesting that in this particular sample, the
effect of GW501516 overcame the maturation induced transcriptional suppression of
antigen uptake.
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Figure 5
PPARδ agonist
agonist enhanced
enhanced phagocytosis
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of iDC
iDC.
7:| PPARδ
Immature DCs were generated from CD14+CD16- monocytes using GM-CSF and IL-4
for 6 days as previously described. Mature DCs were stimulated with 100 ng/ml of LPS
for an additional 24 hours. DCs were harvested and incubated with latex Beads-Rabbit
IgG-FITC complex at 200:1 (v/v) ratio for 48 hours. Cells were briefly incubated with
trypan blue to quench cell surface staining after incubation. The fluorescent signal
emitted by internalized beads was assessed by flow cytometry. Results from three
healthy donors are shown here. Data are presented as mean  s.e.m. P values were
calculated using two-way ANOVA with Turkey’s multiple comparisons test. P value is
not significant unless otherwise indicated. Relative MFI was calculated as MFI value
of treated sample divided by untreated sample. MFI, mean fluorescent intensity; *P ≤
0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001.
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3.3 Effect of siRNA silencing QKI-5 or PPARδ on phagocytosis by dendritic
cells
Ideally, GW501516 should boost the function of the QKI-5/PPARδ complex.
However, it is still possible any effect that the drug may have on DCs can be attribute
to PPARδ alone, especially when used at high concentration. To corroborate the role
of QKI-5 in phagocytosis, individual siRNAs targeting QKI-5 or PPARδ were used to
suppress their expressions in iDCs and phagocytic activity was evaluated. siRNAs
targeting QKI reduced around 30% to 40% of the QKI mRNA and reduced QKI-5
protein expression to a lesser extent (Fig 8). Similarly, siRNAs targeting PPARδ
reduced around 50% abundance of PPARδ mRNA and decreased the protein
expression to various degrees. Interestingly, targeting PPARδ downregulated the QKI
mRNA abundance but not vice versa. Moreover, targeting either QKI or PPARδ
decreased the protein expressions of both to various extent (Fig 8). Nevertheless, the
phagocytosis activity was decreased in iDCs to different degrees at 48 hours with
siPPARδs conferring the highest suppression (Fig 9). These data strongly suggested
both PPARδ and QKI-5 regulate the phagocytosis activity in iDCs.
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Figure
Immature DCs were generated from CD14+CD16- monocytes using GM-CSF and IL-4
for 6 days as previously described. Two different siRNAs targeting QKI-5 or PPARδ
were tranfected to iDCs at concentration of 50nM using the N-TER transfection reagent
on first day of iDC generation. Negative siRNA control was used to distinguish specific
and non-specific targeting. Culture media containing siRNA were removed 24 hours
post transfection and replenished with fresh media. Cells were harvest for quantitative
RT-PCR (top) and immunoblotting (bottom) to evaluate the effect of silencing. RPL13A
was used as housekeeping gene for normalization in RT-qPCR. Vinculin was
immunoblotted as a loading control. Band intensity was measured by ImageJ to
quantify the protein expression. siControl, siRNA negative control.
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Figure 9: Knocking down QKI-5 or PPARδ impaired phagocytosis capacity of
iDC.
Immature DCs were generated from CD14+CD16- monocytes using GM-CSF and IL-4
for 6 days as previously described. Two different siRNAs targeting QKI-5 or PPARδ
were tranfected to iDCs at concentration of 50nM using the N-TER transfection reagent
on first day of iDC generation. Negative siRNA control was used to distinguish specific
and non-specific targeting. Culture media containing siRNA were removed 24 hours
post transfection and replenished with fresh media. Cells were harvested and
incubated with latex Beads-Rabbit IgG-FITC complex at 200:1 (v/v) ratio for 48 hours.
Cells were briefly incubated with trypan blue to quench cell surface staining after
incubation. The fluorescent signal emitted by internalized beads was assessed by flow
cytometry. n = 3. Data are presented as mean  s.e.m. P values were calculated using
ordinary one-way ANOVA with Dunnett’s comparisons test against the control group.
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Relative MFI was calculated as MFI value of treated sample divided by untreated
sample. P value is not significant unless otherwise indicated. siControl, siRNA negative
control; MFI, mean fluorescent intensity; ***P ≤ 0.001, ****P ≤ 0.0001.
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3.4 Effect of PPARδ agonist on antigen cross-presentation by dendritic cells
To test whether the increase in phagocytic capacity by GW501516 enhances
the antigen cross-presentation by DCs, several approaches were employed.
First, DCs were treated with 12.5 μg/ml of whole MART-1 protein one day before
they were matured using LPS (Fig 10). Once the protein got internalized and crosspresented, these mDCs should be able to re-stimulate HLA-matched antigen-specific
CTLs, i.e. M27 CTLs. M27 peptide pulsed-DCs were used as positive control while NYESO peptide pulsed-DCs and un-pulsed DCs were used as negative controls (Fig 10).
The capacity of DC-induced T cell response was measured as T cell proliferation and
effector cytokine production. M27 CTLs co-cultured with whole MART-1 proteinfedDCs were not activated as they showed no increase in IFNγ, perforin A and Ki67
stainings compared to negative controls, regardless whether they were GW501516
treated or not (Fig 11).
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Figure 10: Experimental scheme for MART-1 whole protein cross-presentation
assay
Immature DCs were generated from CD14+CD16- monocytes using GM-CSF and IL-4
for 6 days as previously described with either GW501516 or vehicle control treatments
on the first day of DC generation. On Day 5, the testing group was treated with 12.5
μg/ml of MART-1 whole protein. On Day 6, DCs were matured with LPS at
concentration of 100 ng/ml before they were co-cultured with M27 CTL at 1:10 ratio.
The positive control group was pulsed with 40 μg/ml of M27 peptide. Cells in negative
control group were either pulsed with 40 μg/ml of NY-ESO peptide or had no antigen
exposure. Two days post DC/T cell co-culture, cells were harvested for assessment
using flow cytometry.
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Figure 11: DCs fed with MART-1 whole protein failed to elicit M27 CTL response
M27 CTLs co-cultured with MART-1 whole protein fed DCs were harvested. Brefeldin
A was used to block the cytokine secretion 18 hours before cells were harvested. Cells
were washed and treated with permeabilization solution before stained with CD8APC/Cy7, Ki67-PE, perforin-PE/Cy7, IFNγ-BV650 and Live/Dead Aqua. Stained cells
were assessed by flow cytometry. The expression analysis of indicated proteins were
gated on CD8+ viable cells. The percentages of cells that were positive for indicated
proteins are shown here. n = 3. Data are presented as mean  s.e.m. P values were
calculated using two-way ANOVA with Turkey’s multiple comparisons test. P value is
not significant unless otherwise indicated.
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Second approach involved treatment of DCs with irradiated tumor cells with high
MART-1 protein expression (A2058 cell line). The tumor cell lysate was present in the
DC culture media for 2 or 5 days before DCs were matured and harvested (Fig 12).
Again, these DCs were subsequently co-cultured with HLA-matched M27 CTLs. The
T cell response was measured as effector cytokine production. DCs that were not fed
with cell lysate were used as negative control and non-fed DCs pulsed with M27
peptides were used as positive control. In addition, M27 CTLs could be directly
activated by the HLA-matched, MART-1 expressing tumor cells (Mel526), but not
A2058 cells since they were HLA-mismatched (Fig 13). DCs co-cultured with MART-1
expressing tumor cell lysate failed to simulate M27 CTLs as shown by granzyme b (Fig
13, top) and IFNγ secretion (Fig 13, bottom), regardless of how long the cell lysate was
present in the DC culture and regardless of whether DCs were treated with GW501516.
Further investigation on these DCs revealed that their co-stimulatory molecule CD80,
CD86 and CD83 are drastically decreased if they were fed with tumor cell lysate (Fig
14), which may partially explain why they were unable to induce CTL response.
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Figure 12: Experimental scheme for A2058 cell cross-presentation assay
Immature DCs were generated from CD14+CD16- monocytes using GM-CSF and IL-4
for 6 days as previously described with either 500nM GW501516 or vehicle control
treatments on the first day of DC generation. On Day 2 or 5, the testing groups were
added irradiated A2058 cells at 1:10 ratio (DC:A2058). On Day 6, DCs were matured
with LPS at concentration of 100 ng/ml before they were co-cultured with M27 CTL at
1:10 ratio. The positive control group was not treated with A2058 cell lysate and pulsed
with 40 μg/ml of M27 peptide. Cells in negative control group were either pulsed with
40 μg/ml of NY-ESO peptide or had no antigen exposure. Two days post DC/T cell coculture, cells were harvested for assessment using flow cytometry.
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Figure 13: DCs fed with A2058 cell lysate failed to elicit M27 CTL response
M27 CTLs co-cultured with A2058 cell lysate fed DCs were harvested. Brefeldin A was
used to block the cytokine secretion 18 hours before cells were harvested. Cells were
washed and treated with permeabilization solution before stained with CD8-APC/Cy7,
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granzyme b-APC and Live/Dead Aqua. Stained cells were assessed by flow cytometry.
The expression analysis of indicated proteins were gated on CD8+ viable cells. Before
bredfeldin A was added, cell culture supernatants were harvested and use for ELISA
analysis to detect IFNγ secretion. MFI, mean fluorescent intensity. n = 2. Data are
presented as mean  s.e.m.
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Figure 14: Expressions of co-stimulatory molecules by DCs were downregulated
upon A2058 cell lysate exposure
A2058 cell lysate fed-DCs were generated as previously described. DCs were
harvested for flow cytometry before M27 CTL co-culturing in order to assess the
expression of co-stimulatory molecules. Cells were washed and stained with HLA-DRBV421, CD80-BV510, CD83-BV785, and CD86-BV650 antibodies. Cells were gated
on HLA-DR+ cells. MFI, mean fluorescent intensity.
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A third method to test antigen cross-presentation was the PR1 crosspresentation assay. PR1 is a leukemia-associated, HLA-A2-restricted peptide derived
from neutrophil elastase and protease 3, which are found abundantly in
polymorphonuclear neutrophils (PMN) (Reiter et al., 1997). The 8F4 antibody
specifically recognizes PR1-bound HLA-A2 conformational epitope (Sergeeva et al.,
2016), which can therefore be used to directly measure the PR1/HLA-A2 presented on
DC surface. PMN freeze-thaw lysate was used as source of antigen to feed DCs for
different periods of time and the cross-presentation was evaluated by flow cytometry
using the 8F4 antibody. Two different feeding schemes were used. First, PMN lysate
was added to the DC culture on the day 4 of monocyte differentiation process while
DCs were at the immature stage (Fig 15). iDCs were harvested on Day 5 or Day 6
when they have been exposed to PMN lysate for 24 or 48 hours, respectively. Another
group of PMN lysate fed cells were matured by LPS on Day 6 and harvested 1- or 2days post maturation. They had been exposed to PMN lysate for 72 or 96 hours. PR1
peptide pulsed or unpulsed iDCs and mDCs were used as control. Peptide pulsed cells
showed higher 8F4 stainings in both iDCs and mDCs (Fig 16), indicating 8F4 as a
reliable marker to test the cross-presented PR1/HLA-A2. Matured DCs presented more
PR1 than iDCs in a time-dependent manner (Fig 17), as maturation generally promotes
the expression of MHC molecules. However, regardless of how long that DCs were
exposed to PMN lysate, GW501516 treated iDCs and mDCs did not show higher 8F4
staining as compared to untreated or vehicle control treated counterparts (Fig 17).
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Figure 15: Experimental scheme 1 for PR1 cross-presentation assay
Immature DCs were generated from CD14+CD16- monocytes using GM-CSF and IL-4
for 6 days as previously described with either 500nM GW501516 or vehicle control
treatments on the first day of DC generation. On Day 4, PMN lysate was added to the
cell culture at 3:1 ratio (i.e. 3 PMNs to 1 DC). Cells in group 1 and group 2 were
harvested for 8F4 staining and flow cytometry analysis 24 or 48 hour later, respectively.
Another two groups of DCs were matured on day 6 using 100 ng/ml of LPS and
harvested 24- or 48-hours post maturation. PMN, polymorphonuclear neutrophils.
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Figure 16: The 8F4 staining on PR1 peptide pulsed or unpulsed DCs
Immature DCs were generated from CD14+CD16- monocytes using GM-CSF and IL-4
for 6 days as previously described. Maturation was induced using 100 ng/ml of LPS on
day 6. Matured DCs were harvested 24 hours after. Both iDCs and mDCs were
subjected to 8F4 staining and assessed by flow cytometry. DCs were gated on CD209+
and CD62L- population. FMO, fluorescent minus one.
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Figure 17: The 8F4 staining on PMN lysate fed DCs
Immature and mature DCs exposed to PMN lysate following the feeding scheme 1
were harvested and subjected to 8F4 staining and assessed by flow cytometry. DCs
were gated on CD209+ and CD62L- population. Histograms of 8F4 expression (top)
and bar graphs of MFI (bottom) are shown here. FMO, fluorescent minus one; MFI,
mean fluorescent intensity; PMN, polymorphonuclear neutrophils.
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In the second scheme, iDCs and mDCs were generated without exposure to the
PMN lysate. After iDCs and mDCs were harvested on Day 7, they were counted and
re-plated with PMN cell lysate following incubation for indicated periods of time (Fig
18). The 8F4 staining, which reflected the expression of PR1/HLA-A2 on the cell
surface, showed no significant difference between DCs treated with vehicle control or
GW501516 (Fig 19), indicating GW501516 did not affect DC cross-presentation.
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Figure 18: Experimental scheme 2 for PR1 cross-presentation assay
Immature DCs and mature DCs were generated from CD14+CD16- monocytes using
GM-CSF and IL-4 for 7 days as previously described with either 500nM GW501516 or
vehicle control treatments on the first day of DC generation. LPS was used to mature
the cells at concentration of 100 ng/ml. Cells were harvested on day 7 and co-cultured
with PMN cell lysate at 1:3 ratio (1 DC to 3 PMNs). The DC/PMN mixtures were
incubated for extra 4 days and assessed for PR1/HLA-A2 expression at different time
points. PMN, polymorphonuclear neutrophils.
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Figure 19: The 8F4 staining on PMN lysate fed DCs
Immature and mature DCs exposed to PMN lysate according the feeding scheme 2
were harvested and subjected to 8F4 staining and assessed by flow cytometry. DCs
were gated on CD209+ and CD62L- population. n = 3. Data are presented as mean 
s.e.m. P values were calculated using two-way ANOVA with Turkey’s multiple
comparisons test. MFI, mean fluorescent intensity; ns, not significant.
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Chapter 4: Discussion
The work presented here sheds light on the regulation of antigen uptake and
cross-presentation by human dendritic cells. It demonstrates here a previously
unknown/novel function of an RNA-binding protein, QKI as a positive regulator of
phagocytosis by DCs. In addition, the previously proposed function of QKI-5/PPARδ
complex that QKI-5 can function independently of its RNA-binding activity was
validated in the human primary DCs. This study showed that QKI-5 can act as a coactivator for the nuclear receptor PPARδ and enhance the downstream gene activation
in human DCs. However, the most common heterodimerization partner of PPARδ,
RXRα was expressed in iDCs at very low level, not comparable to the PPARδ
expression and not present in mDCs. This suggests that previously discovered QKI5/PPARδ/RXRα interaction is cell type dependent and there may be other nuclear
receptors forming heterodimers with PPARδ and could be co-activated by QKI-5.
In addition, the co-immunoprecipitation of PPARδ revealed that only a fraction
of QKI-5 was associated with PPARδ, indicating QKI-5 also has other functions
independent of the QKI-5/PPARδ complex. However, we demonstrated here that
enhancing PPARδ function by GW501516 increased the phagocytosis by DCs while
silencing PPARδ or QKI-5 showed the opposite effect. These data strongly suggest
the role of the QKI-5/PPARδ complex in regulating the phagocytosis by iDCs. Although
the mechanism was not investigated in this study, it is possible that the upregulation
phagosome/endosome signaling by QKI results in the enhanced phagocytosis.
Once DCs become mature, they are considered to transcriptionally slow down
the antigen uptake machinery and switch to antigen presentation. In one sample,
GW501516 enhanced the beads uptake by iDCs and this effect persisted even after
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the cells had matured, indicating that GW501516 can help in overcoming the
transcriptional suppression of antigen uptake. However, this was only observed in one
out of three samples. This donor variation could be explained by the existence of single
nucleotide polymorphism in close proximity to qk gene, which was shown to affect the
function of QKI-5 in myocardial tissue (Dehghan et al., 2016). This postulation needs
to be further investigated on a larger number of samples before arriving at a firm
conclusion.
It has been demonstrated monocytes from QKI-haploinsufficient atherosclerotic
patients have reduced capacity to differentiate under M-CSF or GM-CSF (De Bruin et
al., 2016). However, our experiments manipulating QKI-5/PPARδ function (either by
siRNA silencing or by agonist treatment) did not affect DC morphology or the number
of DC generated from a fixed number of monocytes (data not shown), suggesting no
significant impairment of monocyte differentiation was observed in our experimental
system. The discrepancy between two studies can be explained by the fact that there
other confounding factors that affect monocyte differentiation maybe present in
atherosclerotic patient sample and were absent in healthy donor samples that we used.
Moreover, we used GM-CSF in combination with IL-4 to induce monocyte
differentiation where IL-4 is specifically used to create the inflammatory phenotype.
The differences in the experimental systems made comparison of the two studies
difficult. Yet, both studies indicated the importance of QKI in monocytemacrophage/monocyte-DC axis.
Our study tried to assess cross-presentation by GW501516-treated DCs. Using
tumor antigens and established CTL lines, the capability of DCs to activate T cells was
evaluated by effector cytokine production by T cells. However, this approach was not
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a direct measurement of DC cross-presentation. The capability of DCs to activate T
cells cannot fully represent the amount of pMHC present on the DC surface since it
can also be affected by other factors such as co-stimulatory molecules and cytokines
presented or secreted by DCs. Indeed, we found tumor cell lysate fed-DCs failed to
induce T cell response, regardless whether they were GW501516 treated or not,
suggesting this experimental approach was not optimal. Furthermore, co-stimulatory
molecules (CD80, CD86, and CD83) were significantly downregulated in tumor cell
lysate fed DCs, which partially explained why CTLs were not activated.
The monoclonal antibody 8F4 has been used in several studies and clinical trials
where their strong and specific binding to PR1-A2 conformational epitope have been
demonstrated. Therefore, it is considered a reliable and direct measurement of DC
cross-presentation. In our PR1 cross-presentation experiment, there was no increase
in 8F4 staining in GW501516-treated DCs as compared to vehicle control, indicating
they cross-presented similar level of PR-1 peptide. Therefore, it can be concluded that
GW501516 does not enhance DC cross-presentation. The QKI-5/PPARδ may not
directly regulate antigen cross-presentation by DC.
Our initial hypothesis assumed that enhanced antigen uptake will lead to
increased antigen cross-presentation, i.e. more the cells ingest, greater will be the
antigen presentation. However, the study led to the recognition that cellular regulation
of cross-presentation is a highly complex phenomenon involving several different
pathways and our approach was limited in addressing that complexity. Enhancing
phagocytosis by QKI-5, likely due to its regulation on endosome/phagosome signaling,
does not necessarily improve cross-presentation as shown by our data.
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Instead, antigen cross-presentation is a complex process that requires the
coordination among endosome/phagosome signaling, lysosomal acidification,
cytosolic

proteases.

After

antigen

being

taken

up

and

forming

early

endosomes/phagosomes, the antigen-containing vesicles need to go through a serial
step of maturation and trafficking before reaching to the final cross-presenting
organelle. Two major pathways where antigens are processed have been proposed
(Fig 1). In the vacuolar pathway, antigens remain in the endosomal compartment. Their
encounter with proteases and empty MHC Class I molecules is achieved by fusing with
proteases-containing lysosomes and MHC Class I-containing recycling endosomes.
Antigens processed in the cytosolic pathways require extensive transportation in and
out of different endosomal and ER compartments. Each step is precisely controlled in
DC to generate and preserve immunogenic peptides for cross-presentation. For
example, Rab27a induces the fusion of NOX2-containing lysosomes to antigencontaining compartments. Rab11a and Rab22a maintain the intracellular pool of MHC
class I molecules. Silencing these proteins does not affect antigen uptake but impairs
cross-presentation. Modulating antigen uptake alone may not perturb the following
antigen processing and cross-presenting steps. There may exist other mechanisms
regulating each step involved in antigen-presentation so that this first event in adaptive
immunity is tightly controlled.
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Supplementary Figure 1: PPARδ enhanced the phagocytic capacity of iDC
Immature DCs were generated from CD14+CD16- monocytes using GM-CSF and IL4 for 6 days as previously described. Mature DCs were stimulated with 100 ng/ml of
LPS for an additional 24 hours. DCs were harvested and incubated with latex BeadsRabbit IgG-FITC complex at 200:1 (v/v) ratio for indicated periods of time. Cells were
briefly incubated with trypan blue to quench cell surface staining after incubation. The
fluorescent signal emitted by internalized beads was assessed by flow cytometry.
Results from three healthy donors (Top, Middle, and Bottom) are shown here. Data
are presented as mean  s.e.m.
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Supplementary Figure 2: Knocking down QKI-5 or PPARδ impaired
phagocytosis capacity of iDC.
Immature DCs were generated from CD14+CD16- monocytes using GM-CSF and IL-4
for 6 days as previously described. Two different siRNAs targeting QKI-5 or PPARδ
were tranfected to iDCs at concentration of 50nM using the N-TER transfection reagent
on first day of iDC generation. Negative siRNA control was used to distinguish specific
and non-specific targeting. Culture media containing siRNA were removed 24 hours
post transfection and replenished with fresh media. Cells were harvested and
incubated with latex Beads-Rabbit IgG-FITC complex at 200:1 (v/v) ratio for indicated
periods of time. Cells were briefly incubated with trypan blue to quench cell surface
staining after incubation. The fluorescent signal emitted by internalized beads was
assessed by flow cytometry. n = 3. Data are presented as mean  s.e.m. siControl,
siRNA negative control; MFI, mean fluorescent intensity.
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